Connie Asher, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 100 N Pond Dr, Suite A, Walled Lake, MI 48390 Phone: 248-420-7470 |
Amy Lois Anderson Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1010 E West Maple Rd Ste 100, Walled Lake, MI 48390 Phone: 248-313-2900 |
Ms. Danielle Alexis Knighton, LLMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1010 E West Maple Rd Ste 100, Walled Lake, MI 48390 Phone: 248-313-2900 |
Diane Lonnerstater Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1010 E West Maple Rd, Walled Lake, MI 48390 Phone: 248-313-2900 |
Julie Margaret Hudson, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1350 E West Maple Rd, Suite 5, Walled Lake, MI 48390 Phone: 248-496-7558 Fax: 248-624-4216 |
Ms. Jeffrie Kon Cape, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1350 E West Maple Rd, Ste 8, Walled Lake, MI 48390 Phone: 248-730-0690 |
Ashley Gray, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 16201 Caitlin Cir, Walled Lake, MI 48390 Phone: 248-981-7274 |
Mrs. Laura Kaye Johnson-hughes, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1010 E West Maple Rd, Walled Lake, MI 48390 Phone: 248-313-2900 |
Mr. Paul Witri, LLMSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 1010 E West Maple Rd, Walled Lake, MI 48390 Phone: 248-313-2908 |
Lyndsey Sleek-ristich, LMSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1010 E West Maple Rd, Walled Lake, MI 48390 Phone: 248-313-2900 |
News Archive
The Carol Milgard Breast Center was awarded the highest quality review possible by the Food and Drug Administration (FDA) for adhering to the most rigorous quality and safety standards set forth by the Mammography Quality Standards Act (MQSA).
Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today the publication of research from the labs of Stanford scientist and Eiger Founder, Dr. Jeffrey Glenn, M.D., Ph.D. and colleagues entitled, "Identification of a Novel Class of HCV Inhibitors". Published in the January 20th edition of Science and Translational Medicine, the research validates a domain, termed 4BAH2, within the non-structural protein (NS4B) of the HCV genome, as essential for HCV replication and describes the development of a high-throughput screen leading to the identification of small molecule inhibitors of 4BAH2.
Up to half of people with Alzheimer's disease use a psychotropic drug, and one in five uses two or more psychotropics concomitantly, according to a study conducted at the University of Eastern Finland.
Researchers from Seattle Children's Research Institute and the University of Washington described a high-throughput and rapid technique to quantify circulating levels of functional antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), suggesting that the entire viral spike protein should be used to characterize the immune response. Their paper is currently available on the medRxiv* preprint server.
The institute will be operated by the Asbestos Research Foundation will be an affiliate research institute with the The University of Sydney.
› Verified 9 days ago